{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:58Z","timestamp":1780718518595,"version":"3.54.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-123462OB-I00"],"award-info":[{"award-number":["PID2021-123462OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-146632OB-I00"],"award-info":[{"award-number":["PID2023-146632OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-122473OA-I00"],"award-info":[{"award-number":["PID2021-122473OA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00288"],"award-info":[{"award-number":["2021 SGR 00288"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"CIBERNED","doi-asserted-by":"crossref","award":["Grant CB06\/05\/2004"],"award-info":[{"award-number":["Grant CB06\/05\/2004"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut de neurociencies","award":["CEX2021-001159-M"],"award-info":[{"award-number":["CEX2021-001159-M"]}]},{"name":"Serra Hunter Contract","award":["EBLE-9051"],"award-info":[{"award-number":["EBLE-9051"]}]},{"name":"Serra Hunter Contract","award":["UB-LE-9115"],"award-info":[{"award-number":["UB-LE-9115"]}]},{"name":"Serra Hunter contract","award":["UB-LE-9035"],"award-info":[{"award-number":["UB-LE-9035"]}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02321-9","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:28:01Z","timestamp":1780716481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Licochalcone a enhances cognitive resilience in APP\/PS1 Mice by modulating glucose metabolism, A\u03b2 burden, and neuroinflammation"],"prefix":"10.1007","author":[{"given":"Marina","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Olloquequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Verdaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Prohens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Auladell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-7297","authenticated-orcid":false,"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"2321_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"key":"2321_CR2","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","volume":"83","author":"JL Cummings","year":"2023","unstructured":"Cummings JL, Osse AML, Kinney JW. Alzheimer\u2019s disease: novel targets and investigational drugs for disease modification. Drugs. 2023;83:1387\u2013408. https:\/\/doi.org\/10.1007\/s40265-023-01938-w.","journal-title":"Drugs"},{"key":"2321_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y.","journal-title":"Nat Rev Dis Primers"},{"key":"2321_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jare.2023.01.006","volume":"54","author":"FJ Rodriguez-Jimenez","year":"2023","unstructured":"Rodriguez-Jimenez FJ, Ure\u00f1a-Peralta J, Jendelova P, Erceg S. Alzheimer\u2019s disease and synapse loss: what can we learn from induced pluripotent stem cells? J Adv Res. 2023;54:105\u201318. https:\/\/doi.org\/10.1016\/j.jare.2023.01.006.","journal-title":"J Adv Res"},{"issue":"2","key":"2321_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement. 2023;9. https:\/\/doi.org\/10.1002\/trc2.12385.","journal-title":"Alzheimers Dement"},{"key":"2321_CR6","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","volume":"389","author":"RJ Bateman","year":"2023","unstructured":"Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, et al. Two phase 3 trials of Gantenerumab in early Alzheimer\u2019s disease. N Engl J Med. 2023;389:1862\u201376. https:\/\/doi.org\/10.1056\/NEJMoa2304430.","journal-title":"N Engl J Med"},{"key":"2321_CR7","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, et al. Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2023. https:\/\/doi.org\/10.14283\/jpad.2023.30.","journal-title":"J Prev Alzheimers Dis"},{"key":"2321_CR8","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.34","author":"J Cummings","year":"2022","unstructured":"Cummings J, Rabinovici GD, Atri A, Aisen P, Apostolova LG, Hendrix S, et al. Aducanumab: appropriate use recommendations update. J Prev Alzheimers Dis. 2022. https:\/\/doi.org\/10.14283\/jpad.2022.34.","journal-title":"J Prev Alzheimers Dis"},{"key":"2321_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-231198","volume":"97","author":"LA Digma","year":"2024","unstructured":"Digma LA, Winer JR, Greicius MD. Substantial doubt remains about the efficacy of anti-amyloid antibodies. J Alzheimers Dis. 2024;97:567\u201372. https:\/\/doi.org\/10.3233\/JAD-231198.","journal-title":"J Alzheimers Dis"},{"key":"2321_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-med-051022-043645","volume":"75","author":"JL Heidebrink","year":"2024","unstructured":"Heidebrink JL, Paulson HL. Lessons learned from approval of Aducanumab for Alzheimer\u2019s disease. Annu Rev Med. 2024;75:99\u2013111. https:\/\/doi.org\/10.1146\/annurev-med-051022-043645.","journal-title":"Annu Rev Med"},{"key":"2321_CR11","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL. The Amyloid-\u03b2 Oligomer Hypothesis: beginning of the third decade. J Alzheimers Dis. 2018;64:S567-610. https:\/\/doi.org\/10.3233\/JAD-179941.","journal-title":"J Alzheimers Dis"},{"key":"2321_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914499","volume":"24","author":"E Fedele","year":"2023","unstructured":"Fedele E. Anti-amyloid therapies for Alzheimer\u2019s disease and the Amyloid Cascade Hypothesis. Int J Mol Sci. 2023;24:14499. https:\/\/doi.org\/10.3390\/ijms241914499.","journal-title":"Int J Mol Sci"},{"key":"2321_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102161","volume":"93","author":"A Granzotto","year":"2024","unstructured":"Granzotto A, Sensi SL. Once upon a time, the Amyloid Cascade Hypothesis. Ageing Res Rev. 2024;93:102161. https:\/\/doi.org\/10.1016\/j.arr.2023.102161.","journal-title":"Ageing Res Rev"},{"key":"2321_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020536","volume":"13","author":"F Bermejo-Pareja","year":"2024","unstructured":"Bermejo-Pareja F, del Ser T. Controversial past, splendid present, unpredictable future: a brief review of Alzheimer disease history. J Clin Med. 2024;13:536. https:\/\/doi.org\/10.3390\/jcm13020536.","journal-title":"J Clin Med"},{"key":"2321_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2013.00059","volume":"7","author":"MA Meraz-R\u00edos","year":"2013","unstructured":"Meraz-R\u00edos MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hern\u00e1ndez J, Campos-Pe\u00f1a V. Inflammatory process in Alzheimer\u2019s disease. Front Integr Neurosci. 2013;7:59. https:\/\/doi.org\/10.3389\/fnint.2013.00059.","journal-title":"Front Integr Neurosci"},{"key":"2321_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease \u2013 is this type 3 diabetes? J Alzheimers Dis. 2005;7:63\u201380. https:\/\/doi.org\/10.3233\/JAD-2005-7107.","journal-title":"J Alzheimers Dis"},{"key":"2321_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00129","volume":"14","author":"CC Walton","year":"2020","unstructured":"Walton CC, Begelman D, Nguyen W, Andersen JK. Senescence as an amyloid cascade: the Amyloid Senescence Hypothesis. Front Cell Neurosci. 2020;14:129. https:\/\/doi.org\/10.3389\/fncel.2020.00129.","journal-title":"Front Cell Neurosci"},{"key":"2321_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH. Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev. 2021;65:101208. https:\/\/doi.org\/10.1016\/j.arr.2020.101208.","journal-title":"Ageing Res Rev"},{"key":"2321_CR19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging. 2006;27:1372\u201384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012.","journal-title":"Neurobiol Aging"},{"key":"2321_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-180942","volume":"68","author":"EJ Aiello Bowles","year":"2019","unstructured":"Aiello Bowles EJ, Crane PK, Walker RL, Chubak J, LaCroix AZ, Anderson ML, et al. Cognitive resilience to Alzheimer\u2019s disease pathology in the human brain. J Alzheimers Dis. 2019;68:1071\u201383. https:\/\/doi.org\/10.3233\/JAD-180942.","journal-title":"J Alzheimers Dis"},{"key":"2321_CR21","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837\u201344. https:\/\/doi.org\/10.1212\/01.wnl.0000219668.47116.e6.","journal-title":"Neurology"},{"key":"2321_CR22","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197\u2013204. https:\/\/doi.org\/10.1212\/01.wnl.0000271090.28148.24.","journal-title":"Neurology"},{"issue":"8","key":"2321_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archneurol.2011.157","volume":"68","author":"JA Sonnen","year":"2011","unstructured":"Sonnen JA. Ecology of the aging human brain. Arch Neurol. 2011;68:1049. https:\/\/doi.org\/10.1001\/archneurol.2011.157.","journal-title":"Arch Neurol"},{"key":"2321_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1073858420945964","volume":"27","author":"CK Walker","year":"2021","unstructured":"Walker CK, Herskowitz JH. Dendritic spines: mediators of cognitive resilience in aging and Alzheimer\u2019s disease. Neuroscientist. 2021;27:487\u2013505. https:\/\/doi.org\/10.1177\/1073858420945964.","journal-title":"Neuroscientist"},{"key":"2321_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/JAD-210607","volume":"87","author":"FK Kok","year":"2022","unstructured":"Kok FK, van Leerdam SL, de Lange ECM. Potential mechanisms underlying resistance to dementia in non-demented individuals with Alzheimer\u2019s disease neuropathology. J Alzheimers Dis. 2022;87:51\u201381. https:\/\/doi.org\/10.3233\/JAD-210607.","journal-title":"J Alzheimers Dis"},{"key":"2321_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcdb.2022.03.032","volume":"139","author":"AQ Pham","year":"2023","unstructured":"Pham AQ, Dore K. Novel approaches to increase synaptic resilience as potential treatments for Alzheimer\u2019s disease. Semin Cell Dev Biol. 2023;139:84\u201392. https:\/\/doi.org\/10.1016\/j.semcdb.2022.03.032.","journal-title":"Semin Cell Dev Biol"},{"key":"2321_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, Day CM, Abdella S, Garg S. Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Control Release. 2024;367:402\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.047.","journal-title":"J Control Release"},{"key":"2321_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115869","volume":"302","author":"M Cai","year":"2023","unstructured":"Cai M, Xu Y, Deng B, Chen J-B, Chen T-F, Zeng K-F, et al. Radix glycyrrhizae extract and licochalcone A exert an anti-inflammatory action by direct suppression of toll like receptor 4. J Ethnopharmacol. 2023;302:115869. https:\/\/doi.org\/10.1016\/j.jep.2022.115869.","journal-title":"J Ethnopharmacol"},{"key":"2321_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1074506","author":"N Deng","year":"2023","unstructured":"Deng N, Qiao M, Li Y, Liang F, Li J, Liu Y. Anticancer effects of licochalcones: a review of the mechanisms. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1074506.","journal-title":"Front Pharmacol"},{"key":"2321_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s11064-021-03244-x","volume":"46","author":"P Li","year":"2021","unstructured":"Li P, Yu C, Zeng FS, Fu X, Yuan XJ, Wang Q, et al. Licochalcone A attenuates chronic neuropathic pain in rats by inhibiting microglia activation and inflammation. Neurochem Res. 2021;46:1112\u20138. https:\/\/doi.org\/10.1007\/s11064-021-03244-x.","journal-title":"Neurochem Res"},{"key":"2321_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1453426","author":"M Liu","year":"2024","unstructured":"Liu M, Du Y, Gao D. Licochalcone A: a review of its pharmacology activities and molecular mechanisms. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1453426.","journal-title":"Front Pharmacol"},{"key":"2321_CR32","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1021\/acs.jafc.0c07630","volume":"69","author":"Z Luo","year":"2021","unstructured":"Luo Z, Fu C, Li T, Gao Q, Miao D, Xu J, et al. Hypoglycemic effects of Licochalcone A on the Streptozotocin-induced diabetic mice and its mechanism study. J Agric Food Chem. 2021;69:2444\u201356. https:\/\/doi.org\/10.1021\/acs.jafc.0c07630.","journal-title":"J Agric Food Chem"},{"key":"2321_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ptr.8044","volume":"38","author":"D Wang","year":"2024","unstructured":"Wang D, Yang L, Ding W, Chen Z, Yang X, Jiang Y, et al. Licochalcone A alleviates abnormal glucolipid metabolism and restores energy homeostasis in diet\u2010induced diabetic mice. Phytother Res. 2024;38:196\u2013213. https:\/\/doi.org\/10.1002\/ptr.8044.","journal-title":"Phytother Res"},{"key":"2321_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/bph.15999","volume":"180","author":"W Zhu","year":"2023","unstructured":"Zhu W, Wang M, Jin L, Yang B, Bai B, Mutsinze RN, et al. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). Br J Pharmacol. 2023;180:1114\u201331. https:\/\/doi.org\/10.1111\/bph.15999.","journal-title":"Br J Pharmacol"},{"key":"2321_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1142\/S0192415X18500799","volume":"46","author":"Y-J Chiu","year":"2018","unstructured":"Chiu Y-J, Lee C-M, Lin T-H, Lin H-Y, Lee S-Y, Mesri M, et al. Chinese herbal medicine, Glycyrrhiza inflata, reduces A\u03b2 aggregation and exerts neuroprotection through anti-oxidation and anti-inflammation. Am J Chin Med. 2018;46:1535\u201359. https:\/\/doi.org\/10.1142\/S0192415X18500799.","journal-title":"Am J Chin Med"},{"key":"2321_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10753-015-0281-3","volume":"39","author":"J Hu","year":"2016","unstructured":"Hu J, Liu J. Licochalcone A attenuates lipopolysaccharide-induced acute kidney injury by inhibiting NF-\u03baB activation. Inflammation. 2016;39:569\u201374. https:\/\/doi.org\/10.1007\/s10753-015-0281-3.","journal-title":"Inflammation"},{"key":"2321_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108500","volume":"122","author":"M Fang","year":"2023","unstructured":"Fang M, Su K, Wang X, Guan P, Hu X. Study on molecular mechanisms of destabilizing A\u03b2(1\u201342) protofibrils by licochalcone A and licochalcone B using molecular dynamics simulations. J Mol Graph Model. 2023;122:108500. https:\/\/doi.org\/10.1016\/j.jmgm.2023.108500.","journal-title":"J Mol Graph Model"},{"key":"2321_CR38","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/cns.13058","volume":"24","author":"SY Lee","year":"2018","unstructured":"Lee SY, Chiu YJ, Yang SM, Chen CM, Huang CC, Lee-Chen GJ, et al. Novel synthetic chalcone-coumarin hybrid for A\u03b2 aggregation reduction, antioxidation, and neuroprotection. CNS Neurosci Ther. 2018;24:1286\u201398. https:\/\/doi.org\/10.1111\/cns.13058.","journal-title":"CNS Neurosci Ther"},{"key":"2321_CR39","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1016\/j.wneu.2021.10.098","volume":"157","author":"J Guo","year":"2022","unstructured":"Guo J, Xue J, Ding Z, Li X, Wang X, Xue H. Activated Phosphoinositide 3-Kinase\/Akt\/Mammalian Target of Rapamycin signal and suppressed autophagy participate in protection offered by Licochalcone A against Amyloid-\u03b2 peptide fragment 25\u201335\u2013induced injury in SH-SY5Y cells. World Neurosurg. 2022;157:e390-400. https:\/\/doi.org\/10.1016\/j.wneu.2021.10.098.","journal-title":"World Neurosurg"},{"key":"2321_CR40","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.18632\/aging.202704","volume":"13","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zhu J, Liu H, Liu H. Licochalcone A improves the cognitive ability of mice by regulating T- and B-cell proliferation. Aging. 2021;13:8895\u2013915. https:\/\/doi.org\/10.18632\/aging.202704.","journal-title":"Aging"},{"key":"2321_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/08919887241295730","author":"Y Fan","year":"2024","unstructured":"Fan Y, Ling Y, Zhou X, Li K, Zhou C. Licochalcone A ameliorates cognitive dysfunction in an Alzheimer\u2019s disease model by inhibiting endoplasmic reticulum stress-mediated apoptosis. J Geriatr Psychiatry Neurol. 2024. https:\/\/doi.org\/10.1177\/08919887241295730.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2321_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"2321_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01106-8","volume":"31","author":"M Carrasco","year":"2025","unstructured":"Carrasco M, Guzman L, Olloquequi J, Cano A, Fortuna A, Vazquez-Carrera M, et al. Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model. Mol Med. 2025;31:54. https:\/\/doi.org\/10.1186\/s10020-025-01106-8.","journal-title":"Mol Med"},{"key":"2321_CR44","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"},{"key":"2321_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93\u2013110. https:\/\/doi.org\/10.1007\/s10339-011-0430-z.","journal-title":"Cogn Process"},{"key":"2321_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exger.2016.12.019","volume":"88","author":"L Macklin","year":"2017","unstructured":"Macklin L, Griffith CM, Cai Y, Rose GM, Yan X-X, Patrylo PR. Glucose tolerance and insulin sensitivity are impaired in APP\/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline. Exp Gerontol. 2017;88:9\u201318. https:\/\/doi.org\/10.1016\/j.exger.2016.12.019.","journal-title":"Exp Gerontol"},{"key":"2321_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41684-024-01473-5","volume":"54","author":"C Moro","year":"2025","unstructured":"Moro C, Magnan C. Revisited guidelines for metabolic tolerance tests in mice. Lab Anim (NY). 2025;54:16\u201323. https:\/\/doi.org\/10.1038\/s41684-024-01473-5.","journal-title":"Lab Anim (NY)"},{"key":"2321_CR48","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"key":"2321_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv. 2018;4:575\u201390. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"2321_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.01.022","volume":"55","author":"Z Mi","year":"2017","unstructured":"Mi Z, Abrahamson EE, Ryu AY, Fish KN, Sweet RA, Mufson EJ, et al. Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer\u2019s disease. Neurobiol Aging. 2017;55:159\u201366. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.022.","journal-title":"Neurobiol Aging"},{"key":"2321_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1871527316666170113120853","volume":"16","author":"SD Skaper","year":"2017","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P. Synaptic plasticity, dementia and Alzheimer disease. CNS Neurol Disord Drug Targets. 2017;16:220\u201333. https:\/\/doi.org\/10.2174\/1871527316666170113120853.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2321_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.neuro.31.060407.125646","volume":"31","author":"JN Bourne","year":"2008","unstructured":"Bourne JN, Harris KM. Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci. 2008;31:47\u201367. https:\/\/doi.org\/10.1146\/annurev.neuro.31.060407.125646.","journal-title":"Annu Rev Neurosci"},{"key":"2321_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.acthis.2008.05.002","volume":"111","author":"J-S Kim","year":"2009","unstructured":"Kim J-S, Jung J, Lee H-J, Kim JC, Wang H, Kim S-H, et al. Differences in immunoreactivities of Ki-67 and doublecortin in the adult hippocampus in three strains of mice. Acta Histochem. 2009;111:150\u20136. https:\/\/doi.org\/10.1016\/j.acthis.2008.05.002.","journal-title":"Acta Histochem"},{"key":"2321_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311\u201322. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(200003)182:3311::AID-JCP13.0.CO;2-9.","journal-title":"J Cell Physiol"},{"key":"2321_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-3806(01)00224-3","volume":"134","author":"G Kempermann","year":"2002","unstructured":"Kempermann G, Gage FH. Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis. Dev Brain Res. 2002;134:1\u201312. https:\/\/doi.org\/10.1016\/S0165-3806(01)00224-3.","journal-title":"Dev Brain Res"},{"key":"2321_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01977-x","volume":"11","author":"SB Arredondo","year":"2021","unstructured":"Arredondo SB, Reyes DT, Herrera-Soto A, Mardones MD, Inestrosa NC, Varela-Nallar L. Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe\/PS1\u0394E9 mouse model of Alzheimer\u2019s disease. Sci Rep. 2021;11:22904. https:\/\/doi.org\/10.1038\/s41598-021-01977-x.","journal-title":"Sci Rep"},{"key":"2321_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111452","volume":"195","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang H, Ma Y. Molecular mechanisms of altered adult hippocampal neurogenesis in Alzheimer\u2019s disease. Mech Ageing Dev. 2021;195:111452. https:\/\/doi.org\/10.1016\/j.mad.2021.111452.","journal-title":"Mech Ageing Dev"},{"key":"2321_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2174\/1567205017666201224162730","volume":"17","author":"S Amber","year":"2021","unstructured":"Amber S, Sumera FJ, Mirza M, Asif D, Hassan T, Ahmed SZ. Amyloid-beta induced neurotoxicity impairs cognition and adult hippocampal neurogenesis in a mouse model for Alzheimer\u2019s disease. Curr Alzheimer Res. 2021;17:1033\u201342. https:\/\/doi.org\/10.2174\/1567205017666201224162730.","journal-title":"Curr Alzheimer Res"},{"key":"2321_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/brain\/awu354","volume":"138","author":"K Richetin","year":"2015","unstructured":"Richetin K, Leclerc C, Toni N, Gallopin T, Pech S, Roybon L, et al. Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer\u2019s disease. Brain. 2015;138:440\u201355. https:\/\/doi.org\/10.1093\/brain\/awu354.","journal-title":"Brain"},{"issue":"9","key":"2321_CR60","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","volume":"72","author":"AA Willette","year":"2015","unstructured":"Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, et al. Association of insulin resistance with cerebral glucose uptake in late middle\u2013aged adults at risk for Alzheimer disease. JAMA Neurol. 2015;72:1013. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0613.","journal-title":"JAMA Neurol"},{"key":"2321_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00784-w","volume":"13","author":"GD Femminella","year":"2021","unstructured":"Femminella GD, Livingston NR, Raza S, van der Doef T, Frangou E, Love S, et al. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer\u2019s subjects? Alzheimers Res Ther. 2021;13:47. https:\/\/doi.org\/10.1186\/s13195-021-00784-w.","journal-title":"Alzheimers Res Ther"},{"key":"2321_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","volume":"77","author":"SM de la Monte","year":"2017","unstructured":"de la Monte SM. Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer\u2019s disease. Drugs. 2017;77:47\u201365. https:\/\/doi.org\/10.1007\/s40265-016-0674-0.","journal-title":"Drugs"},{"key":"2321_CR63","doi-asserted-by":"publisher","first-page":"E678","DOI":"10.1152\/ajpendo.00383.2005","volume":"290","author":"L Jacobson","year":"2006","unstructured":"Jacobson L, Ansari T, McGuinness OP. Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice. Am J Physiol Endocrinol Metab. 2006;290:E678-84. https:\/\/doi.org\/10.1152\/ajpendo.00383.2005.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2321_CR64","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc12-2480","volume":"36","author":"ER Seaquist","year":"2013","unstructured":"Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 2013;36:1384\u201395. https:\/\/doi.org\/10.2337\/dc12-2480.","journal-title":"Diabetes Care"},{"key":"2321_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","volume":"46","author":"K Sharabi","year":"2015","unstructured":"Sharabi K, Tavares CDJ, Rines AK, Puigserver P. Molecular pathophysiology of hepatic glucose production. Mol Aspects Med. 2015;46:21\u201333. https:\/\/doi.org\/10.1016\/j.mam.2015.09.003.","journal-title":"Mol Aspects Med"},{"key":"2321_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123001","volume":"355","author":"J Tran","year":"2024","unstructured":"Tran J, Parekh S, Rockcole J, Wilson D, Parmar MS. Repurposing antidiabetic drugs for Alzheimer\u2019s disease: a review of preclinical and clinical evidence and overcoming challenges. Life Sci. 2024;355:123001. https:\/\/doi.org\/10.1016\/j.lfs.2024.123001.","journal-title":"Life Sci"},{"key":"2321_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102383","volume":"99","author":"Y Peng","year":"2024","unstructured":"Peng Y, Yao S, Chen Q, Jin H, Du M, Xue Y, et al. True or false? Alzheimer\u2019s disease is type 3 diabetes: evidences from bench to bedside. Ageing Res Rev. 2024;99:102383. https:\/\/doi.org\/10.1016\/j.arr.2024.102383.","journal-title":"Ageing Res Rev"},{"key":"2321_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"JL Milstein","year":"2021","unstructured":"Milstein JL, Ferris HA. The brain as an insulin-sensitive metabolic organ. Mol Metab. 2021;52:101234. https:\/\/doi.org\/10.1016\/j.molmet.2021.101234.","journal-title":"Mol Metab"},{"key":"2321_CR69","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","volume":"63","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63:2232\u201343. https:\/\/doi.org\/10.2337\/db14-0568.","journal-title":"Diabetes"},{"key":"2321_CR70","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI99366","volume":"128","author":"W Cai","year":"2018","unstructured":"Cai W, Xue C, Sakaguchi M, Konishi M, Shirazian A, Ferris HA, et al. Insulin regulates astrocyte gliotransmission and modulates behavior. J Clin Invest. 2018;128:2914\u201326. https:\/\/doi.org\/10.1172\/JCI99366.","journal-title":"J Clin Invest"},{"key":"2321_CR71","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20160493","volume":"213","author":"M Stanley","year":"2016","unstructured":"Stanley M, Macauley SL, Holtzman DM. Changes in insulin and insulin signaling in Alzheimer\u2019s disease: cause or consequence? J Exp Med. 2016;213:1375\u201385. https:\/\/doi.org\/10.1084\/jem.20160493.","journal-title":"J Exp Med"},{"key":"2321_CR72","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","volume":"6","author":"C Sims-Robinson","year":"2010","unstructured":"Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6:551\u20139. https:\/\/doi.org\/10.1038\/nrneurol.2010.130.","journal-title":"Nat Rev Neurol"},{"key":"2321_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14:168\u201381. https:\/\/doi.org\/10.1038\/nrneurol.2017.185.","journal-title":"Nat Rev Neurol"},{"key":"2321_CR74","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang H-Y, Kazi H, Han L-Y, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316\u201338. https:\/\/doi.org\/10.1172\/JCI59903.","journal-title":"J Clin Invest"},{"key":"2321_CR75","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S, O\u2019Connor R, Ravid R, O\u2019Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging. 2010;31:224\u201343. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.04.002.","journal-title":"Neurobiol Aging"},{"key":"2321_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C. Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21\u201343. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.06.004.","journal-title":"Prog Neurobiol"},{"key":"2321_CR77","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pflugers Arch. 2020;472:1299\u2013343. https:\/\/doi.org\/10.1007\/s00424-020-02441-x.","journal-title":"Pflugers Arch"},{"key":"2321_CR78","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, et al. GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18:521\u201330. https:\/\/doi.org\/10.1038\/nn.3966.","journal-title":"Nat Neurosci"},{"key":"2321_CR79","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00006676-200010000-00014","volume":"21","author":"X-Z Ding","year":"2000","unstructured":"Ding X-Z, Fehsenfeld DM, Murphy LO, Permert J, Adrian TE. Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas. 2000;21:310\u201320. https:\/\/doi.org\/10.1097\/00006676-200010000-00014.","journal-title":"Pancreas"},{"key":"2321_CR80","doi-asserted-by":"publisher","first-page":"25649","DOI":"10.1074\/jbc.M700651200","volume":"282","author":"K Fulzele","year":"2007","unstructured":"Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. Disruption of the Insulin-like Growth Factor Type 1 Receptor in osteoblasts enhances Insulin signaling and action. J Biol Chem. 2007;282:25649\u201358. https:\/\/doi.org\/10.1074\/jbc.M700651200.","journal-title":"J Biol Chem"},{"key":"2321_CR81","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1152\/ajpendo.1997.273.1.E68","volume":"273","author":"C Taha","year":"1997","unstructured":"Taha C, Tsakiridis T, McCall A, Klip A. Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways. Am J Physiol Endocrinol Metab. 1997;273:E68-76. https:\/\/doi.org\/10.1152\/ajpendo.1997.273.1.E68.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2321_CR82","doi-asserted-by":"publisher","first-page":"24678","DOI":"10.1074\/jbc.270.42.24678","volume":"270","author":"C Taha","year":"1995","unstructured":"Taha C, Mitsumoto Y, Liu Z, Skolnik EY, Klip A. The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters in L6 muscle cells is mediated by distinct pathways. J Biol Chem. 1995;270:24678\u201381. https:\/\/doi.org\/10.1074\/jbc.270.42.24678.","journal-title":"J Biol Chem"},{"key":"2321_CR83","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL. Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 2015;129:183\u2013206. https:\/\/doi.org\/10.1007\/s00401-015-1386-3.","journal-title":"Acta Neuropathol"},{"key":"2321_CR84","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry. 2021;89:745\u201356. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001.","journal-title":"Biol Psychiatry"},{"key":"2321_CR85","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12275-024-00134-z","volume":"62","author":"W Li","year":"2024","unstructured":"Li W, Yin Y, Li T, Wang Y, Shi W. Licochalcone A protects vaginal epithelial cells against Candida albicans infection via the TLR4\/NF-\u03baB signaling pathway. J Microbiol. 2024;62:525\u201333. https:\/\/doi.org\/10.1007\/s12275-024-00134-z.","journal-title":"J Microbiol"},{"key":"2321_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108626","volume":"24","author":"F La Rosa","year":"2023","unstructured":"La Rosa F, Agostini S, Piancone F, Marventano I, Hernis A, Fenoglio C, et al. TREM2 expression and Amyloid-Beta phagocytosis in Alzheimer\u2019s disease. Int J Mol Sci. 2023;24:8626. https:\/\/doi.org\/10.3390\/ijms24108626.","journal-title":"Int J Mol Sci"},{"key":"2321_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0247-7","volume":"13","author":"L Zhong","year":"2018","unstructured":"Zhong L, Wang Z, Wang D, Wang Z, Martens YA, Wu L, et al. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2). Mol Neurodegener. 2018;13:15. https:\/\/doi.org\/10.1186\/s13024-018-0247-7.","journal-title":"Mol Neurodegener"},{"key":"2321_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y.","journal-title":"Nat Rev Neurol"},{"key":"2321_CR89","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective \u03b2-Amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci. 2008;28:8354\u201360. https:\/\/doi.org\/10.1523\/JNEUROSCI.0616-08.2008.","journal-title":"J Neurosci"},{"key":"2321_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010099","volume":"12","author":"MA Adem","year":"2024","unstructured":"Adem MA, Decourt B, Sabbagh MN. Pharmacological approaches using diabetic drugs repurposed for Alzheimer\u2019s disease. Biomedicines. 2024;12:99. https:\/\/doi.org\/10.3390\/biomedicines12010099.","journal-title":"Biomedicines"},{"key":"2321_CR91","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.nbd.2003.08.009","volume":"14","author":"J Wang","year":"2003","unstructured":"Wang J, Tanila H, Puoliv\u00e4li J, Kadish I, van Groen T. Gender differences in the amount and deposition of amyloid\u03b2 in APPswe and PS1 double transgenic mice. Neurobiol Dis. 2003;14:318\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2003.08.009.","journal-title":"Neurobiol Dis"},{"key":"2321_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01295-5","volume":"14","author":"G Qi","year":"2024","unstructured":"Qi G, Tang H, Gong P, Liu Y, He C, Hu J, et al. Sex-specific hypothalamic neuropathology and glucose metabolism in an amyloidosis transgenic mouse model of Alzheimer\u2019s disease. Cell Biosci. 2024;14:120. https:\/\/doi.org\/10.1186\/s13578-024-01295-5.","journal-title":"Cell Biosci"},{"key":"2321_CR93","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 2019;27:1293-1306.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099.","journal-title":"Cell Rep"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02321-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:28:05Z","timestamp":1780716485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":93,"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02321-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals were obtained from established breeding colonies at the Animal Facility of the Faculty of Pharmacy and Food Sciences, University of Barcelona (approval number C-0032) and maintained following the ethical guidelines established by the European Committee (European Communities Council Directive 2010\/63\/EU). All procedures were conducted following the European Community Council Directive 86\/609\/EEC and the guidelines established by the Departament d'Agricultura, Ramaderia i Pesca of the Generalitat de Catalunya. The experimental protocol was approved by the Ethics Committee of the University of Barcelona (approval number CEEA 424\/22).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}